The 11th BioCamp concludes with an award ceremony for the best students
- The 11th BioCamp, which this year hosted 36 young talents from 10 countries in a virtual environment, has come to a close with an award ceremony for the most promising students.
- During the five-day event, participants attended lectures and workshops where they networked with renowned experts and leading executives from the pharmaceutical industry.
- Members of the winning team of BioCamp 2021 are Victor Dupuy, Neža Brezovec, Matej Novak, Doroteja Vujinović, Eva Plut and Aleksandra Roganović.
Novartis Slovenia hosted 36 of the most promising science, economics and engineering students from the region and beyond at the 11th BioCamp. A panel of experts from Novartis and representatives from external partner organizations selected a winning team from among the participants which managed to find the best solution to a specific challenge in the pharmaceutical industry. At the same time, recognitions for outstanding engagement and participation during BioCamp, peer-to-peer recognitions and social media recognition, were also awarded. Members of the winning team are Victor Dupuy, Neža Brezovec, Matej Novak, Doroteja Vujinović, Eva Plut and Aleksandra Roganović. The recognition awards went to Angelika Vižintin from Slovenia for outstanding engagement and participation and Kristijan Topalov from North Macedonia for outstanding engagement and activity on social media platforms. Peer to peer recognition was awarded to one student out of every group and the winners are: Luka Svet, Špela Korat, Eva Gruden, Bruno Marinič, Arijan Valar from Slovenia and Victor Dupuy from France.
The main theme of this year's BioCamp, which, like last year, took place in a virtual environment, was the impact of data and artificial intelligence on the pharmaceutical industry. Young talents learned about the opportunities and challenges that digitization, automation and AI bring to the industry and discussed new ways of working and thinking to find breakthrough pharmaceutical solutions with top experts. An important part of the event was the workshop on future competences, led by Dr. Anja Svetina Nabergoj from Stanford University, where they worked in groups and with mentors to identify which competences are and will be the ones that drive the pharmaceutical industry in the future, how each employee can contribute to the success of the company, and what we can learn from our colleagues and peers.
Students compete to find a concrete solution
As has been typical of BioCamp for many years, the event also presented participants with a practical challenge based on a real-life situation in the pharmaceutical industry – this year, they had to focus their knowledge and creative thinking to come up with innovative solutions to address the pharmaceutical industry's challenges in tackling sickle cell anemia. The task required students to work in teams to develop their business and scientific mindsets, and to demonstrate a high degree of innovation, communication and other teamwork skills. Working in a virtual environment provided an additional challenge, but the students worked even harder to present innovative and creative solutions. Katja Razinger, director of sales operations at Novartis in Slovenia, has participated in board of investors several times and emphasized that students show more innovation and quality of their work every year. »This year’s presentations were exceptional and we really had a hard time deciding on the best team. The students expressed not only the ability of team cooperation within groups, but also between individual groups, which brought even better solutions to the challenge, which was quite demanding. They have proven themselves by thinking outside the box as well as incorporating modern technologies, but mainly, they focused on one thing that Novartis is emphasized at every step – the patient.« In addition to the winning team, three individual prizes were awarded at the event – for the most effective use of social media and for the most outstanding participant, while the students voted for the best participant among themselves as well.
After the event, the winners said:
Victor Dupuy from the winning team: »It’s hard to believe that we win this, as during the preparation of case study, we faced many challenges. But we worked really hard, put all our efforts in and got some really precious advices from other teams and mentors and that was our winning combination. «
Angelika Vižintin for outstanding engagement and participation: »I’m really thankful that this event took place and that organizer made an effort to put it together online. You did a great job and this was seen throughout whole event. What I liked the most was interaction of students from different background and level of knowledge – we were all actively discussing the topics of the event and learned really a lot.«
Luka Svet for peer-to-peer recognition: I’m really surprised by this award; I would really like to thank all the members of my team and I think we all should share this award. When preparing a case study, it was all about team work and that is what really matters. I hope that one day, we’ll all meet in person and share this experience live.
Kristijan Topalov from North Macedonia for outstanding engagement and activity on social media platforms: »Thank you for this award, it’s a great feeling to get this award. I think it’s really important to share the message of BioCamp on social media, so more people, especially students have s chance to know a little about the content and also to raise awareness about health issues, that we tackled. «
Novartis is the leading provider of medicines in Slovenia, where Lek d.d., Novartis Pharma Services Inc., Podružnica v Sloveniji and Sandoz d.d., operate. Together we are building and maintaining the reputation of a dynamic, ethical, and trusted pharmaceutical company. Lek develops, manufactures, and markets effective, safe, and high quality medicines and active pharmaceutical ingredients. With our knowledge, quality, and experience we have gained an important role in Novartis' organizational structure, especially in the Novartis Technical Operations, Global Drug Development, Novartis Business Services, and the generic division Sandoz. We are the leading Sandoz development center, and one of the key development sites for technologically complex projects. We invest a great deal in the development, education, and training of our employees. Over the last nine years, the company has created more than 3,350 new job opportunities, making us one of the biggest employers in Slovenia. Novartis invested in Slovenia more than EUR 2.7 billion since 2003.
Sandoz, a Novartis division, is a global leader in generic pharmaceuticals and biosimilars. Our purpose is to pioneer access for patients by developing and commercializing novel, affordable approaches that address unmet medical needs. Our ambition is to be the world’s leading and most valued generics company. Our broad portfolio of high-quality medicines, covering all major therapeutic areas, accounted for 2020 sales of USD 9.6 billion.
Novartis is reimagining medicine to improve and extend people’s lives. As a leading global medicines company, we use innovative science and digital technologies to create transformative treatments in areas of great medical need. In our quest to find new medicines, we consistently rank among the world’s top companies investing in research and development. Novartis products reach nearly 800 million people globally and we are finding innovative ways to expand access to our latest treatments. About 109,000 people of more than 140 nationalities work at Novartis around the world. Find out more at www.novartis.com.
This press release contains statements and conclusions based on projections of Lek’s future business operations. These estimates are derived from the best information currently available. In case these forecasts prove unreliable, the actual results could prove different from those projected.
For additional information contact:
Communications & External Engagement
Lek Pharmaceuticals d.d.
Phone: +386 1 580 22 43